Celgene Europe BV
5 products tracked · names used in filings: Celgene Europe BV, Celgene Europe Ltd., Celgene Europe Limited
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Idhifa | Application withdrawn | |
| 🇪🇺 | Istodax romidepsin | Refused | |
| 🇪🇺 | Lenalidomide Celgene Europe lenalidomide | Application withdrawn | |
| 🇪🇺 | Azacitidine Celgene azacitidine | Withdrawn | 2019-08-02 |
| 🇪🇺 | Refludan lepirudin | Withdrawn | 1997-03-13 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.